Related Experiment Video

Updated: Jun 13, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Atorvastatin in stroke: a review of SPARCL and subgroup analysis

Branko N Huisa1, Andrew B Stemer, Justin A Zivin

  • 1Department of Neuroscience, University of California, San Diego, CA 92103, USA. bhuisagarate@ucsd.edu

Vascular Health and Risk Management
|April 22, 2010
PubMed

Insights

High-dose statin therapy, like atorvastatin, significantly reduces stroke risk in patients with a history of stroke or TIA. This evidence supports its use for secondary stroke prevention.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Statin therapy is linked to reduced stroke incidence in cardiovascular disease patients.
  • The SPARCL trial investigated atorvastatin's efficacy in stroke/TIA patients.

Purpose of the Study:

  • To evaluate the effectiveness of high-dose atorvastatin for secondary stroke prevention.
  • To analyze subgroup data from the SPARCL trial regarding stroke risk reduction.

Main Methods:

  • Analysis of data from the Stroke Prevention by Aggressive Reduction of Cholesterol Levels (SPARCL) trial.
  • Post hoc subgroup analyses examining factors like age, sex, carotid disease, and stroke type.

Main Results:

  • Daily 80 mg atorvastatin reduced fatal or nonfatal stroke by 16% in recent stroke/TIA patients.
  • No significant differences found across most subgroups, except for intracranial hemorrhage entry events.
  • Lower LDL cholesterol and potential neuroprotective effects of atorvastatin correlate with risk reduction.

Conclusions:

  • High-dose statin therapy is strongly recommended for secondary stroke prevention in stroke and TIA patients.
  • Clinicians should not withhold statin therapy based on subgroup analyses.
  • Further research may explore neuroprotective mechanisms of statins.

Keywords:
carotid stenosisintracranial hemorrhageneuroprotectionoutcomepreventionstatinstransient ischemic attack

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...